This study examined whether life event stress under general or more specific conditions (fear of separation, feeling of being under pressure, feeling of being caught between two quarreling parties, separation experiences) contribute to the aggravation of inflammatory bowel disease (IBD). Firstly, 51 patients with ulcerative colitis, 57 patients with Crohn’s disease, and 60 controls were compared in terms of these variables. In addition, the IBD patients filled out questionnaires asking for life events, the specific psychological conditions mentioned above, and their symptoms every 3 months for 1 year after the first measurement. Patients with Crohn’s disease and patients with ulcerative colitis reported a lower amount of life event stress than members of the control group, but listed more feelings of being under pressure. Within group comparisons between patients in relapse and patients in remission, as well as comparisons between patients with recently increased disease activity and patients without increased disease activity did not yield clear results. We conclude that the variables in question have little influence on the beginning of a relapse.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.